How It Works Tesamorelin binds to GHRH receptors in the anterior pituitary, increasing pulsatile growth hormone and downstream IGF1, which selectively stimulates lipolysis in visceral adipose tissue while largely preserving subcutaneous fat and lean muscle
Both Semaglutide and Tirzepatide are GLP-1 weight loss medications, but Tirzepatide also targets GIP receptors, providing broader effects on insulin and appetite control
They improve insulin sensitivity in peripheral tissues, favorably shift lipid profiles, and exert anti-inflammatory effects across multiple organ systems
This is especially valuable for athletes and bodybuilders aiming to build lean mass while minimizing fat gain
The widespread interest in GLP-1 receptor agonists for weight loss, particularly amid drug shortages, has renewed clinical and regulatory attention to their safety profile, yet the clinical profile of acute exposures remains poorly understood, wrote first author Jordan Miller, a researcher with The University of Texas at San Antonio, and colleagues
In addition, I had been struggling to lose weight for what felt like a decade